The Access to Pediatric Technologies Act of 2025 (HR1931) will accelerate the development and availability of medical devices and drugs for pediatric use. This creates a new market opportunity for pharmaceutical and medical device companies, driving increased R&D and product launches in the pediatric segment.
Impact: 6/10HR1931Congressional Bill